查詢結果分析
相關文獻
- Photodynamic Therapy in the Treatment of Choroidal Neovascularization Complicating Central Serous Chorioretinopathy
- 老年性黃斑部病變之境界不明脈絡膜新生血管的灌流變化
- 循血綠眼底攝影指引雷射治療老年性黃斑部變性之中心窩外境界不明的脈絡膜新生血管
- 老年性視網膜黃斑部變性治療的新發展--經瞳孔熱療法
- 循血綠血管攝影在老年性黃斑部病變之應用及展望
- 牽牛花症候群合併脈絡膜新生血管--病例報告
- The Long-Term Results of One Time Treatment by Continuously Fractionated Transpupillary Thermotherapy for Occult Choroid Neovascularization Membrane of Age-Related Macular Degeneration
- Digital Indocyanine Green Angiography in Chorioretinal Diseases
- Indocyanine Green Videoangiography in the Evaluation of Laser Teatment of Choroidal Neovascularization
- Transpupillary Thermotherapy of Choroidal Neovascularization in Patients with Age-Related Macular Degeneration
頁籤選單縮合
題 名 | Photodynamic Therapy in the Treatment of Choroidal Neovascularization Complicating Central Serous Chorioretinopathy=光動力雷射治療中心性漿液性視網膜病變併發之脈絡膜新生血管 |
---|---|
作 者 | 楊昌叔; 陳冠潔; 李淑美; 李鳳利; | 書刊名 | Journal of the Chinese Medical Association |
卷 期 | 72:9 2009.09[民98.09] |
頁 次 | 頁501-505+CA95 |
分類號 | 416.746 |
關鍵詞 | 中心性漿液性視網膜病變; 脈絡膜新生血管; 光動力雷射療法; Verteporfin; Central serous chorioretinopathy; Choroidal neovascularization; Photodynamic therapy; |
語 文 | 英文(English) |
英文摘要 | We report the favorable anatomic and functional outcome of photodynamic therapy with verteporfin in a case of chronic central serous chorioretinopathy complicated with choroidal neovascularization (CNV). This 37-year-old Chinese male with bilateral chronic central serous chorioretinopathy presented with central scotoma, reduced vision and metamorphopsia in his right eye. Fluorescein angiography (FA) disclosed macular hemorrhage, exudate and subfoveal classic CNV. Photodynamic therapy (PDT) with verteporfin was applied to the CNV according to standard protocol with 2.2-mm spot size. Best-corrected visual acuity (BCVA) improved from 6/20 to 6/10 1 month after PDT. BCVA recovered to 6/7.5 without leakage on FA 3 months after PDT. Neither recurrent CNV lesion nor new hemorrhage was noted over 12 months of follow-up. Short-term results suggest that PDT with verteporfin for CNV secondary to central serous chorioretinopathy is a safe and effective treatment modality. |
本系統中英文摘要資訊取自各篇刊載內容。